Categories: Tech

LECTRA: Monthly declaration of the total number of shares and voting rights composing the company’s capital (at June 30th, 2025)

Monthly declaration of the total number of shares and voting rights composing the company’s capital (at June 30th, 2025)

This declaration is established in accordance with Article L.233-8 II of the French Code de Commerce and of Article 223-11 of the Règlement Général of the Autorité des marchés financiers (AMF).

Date:

June 30th, 2025

Total number of shares composing the capital:

38,037,750

Total number of voting rights, gross (1):

38,037,750

Total number of voting rights, net (2):

38,005,573

(1) In accordance with the second paragraph of article 223-11 of the Règlement Général of the AMF, the gross total of voting rights is based on the total number of shares composing the company’s capital which have voting rights, including shares deprived of their voting rights

(2) The net total of voting rights is equal to the gross total, minus the number of shares deprived of their voting rights (treasury shares)

Other than the legal notification requirements for crossing the thresholds established by French law, there is no special statutory obligation.

GlobeNews Wire

Recent Posts

OMAN’S MUSCAT STOCK EXCHANGE TRADING VALUE UP FIVEFOLD TO USD 8.45 BILLION

MUSCAT, Oman, Nov. 5, 2025 /PRNewswire/ -- Oman's Muscat Stock Exchange (MSX) has recorded its strongest…

3 hours ago

Wahed and KraneShares Announce the Launch of KWIN: A Shariah-Compliant Alternative Income ETF for Faith-Aligned Investors

NEW YORK, Nov. 5, 2025 /PRNewswire/ -- Wahed, a global leader in Shariah-compliant digital investing,…

3 hours ago

Litecoin Creator Charlie Lee Joins SilentSwap as Strategic Advisor to Advance Privacy Infrastructure for Digital Assets

Cryptocurrency Pioneer Brings Deep Technical Expertise and Vision for Financial Privacy to Next-Generation Cross-Chain Platform…

5 hours ago

IBM and Agassi Sports Entertainment Announce AI-Powered Platform to Advance Global Racquet Sports

Partnering to deliver a digital platform with AI-powered video coaching, premium content, and commercial experiences…

5 hours ago

Curonix Strengthens Executive Leadership with Appointment of Leading Medical Device Executive Russell Fleeger as Chief Financial Officer to Drive Next Stage of Growth

POMPANO BEACH, Fla., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Curonix LLC (“Curonix” or the “Company”),…

8 hours ago

LENZ Therapeutics Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights

November 05, 2025 08:00 ET  | Source: LENZ Therapeutics, Inc. VIZZTM (aceclidine ophthalmic solution) 1.44%…

8 hours ago